- Home
- PD vs RCKT Comparison
PD vs RCKT Comparison
Compare PD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PD
- RCKT
- Stock Information
- Founded
- PD 2009
- RCKT 1999
- Country
- PD United States
- RCKT United States
- Employees
- PD N/A
- RCKT N/A
- Industry
- PD Computer Software: Prepackaged Software
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- PD Technology
- RCKT Health Care
- Exchange
- PD Nasdaq
- RCKT Nasdaq
- Market Cap
- PD 1.4B
- RCKT 264.0M
- IPO Year
- PD 2019
- RCKT N/A
- Fundamental
- Price
- PD $14.90
- RCKT $3.00
- Analyst Decision
- PD Buy
- RCKT Buy
- Analyst Count
- PD 12
- RCKT 13
- Target Price
- PD $19.50
- RCKT $18.50
- AVG Volume (30 Days)
- PD 1.6M
- RCKT 3.8M
- Earning Date
- PD 09-02-2025
- RCKT 08-04-2025
- Dividend Yield
- PD N/A
- RCKT N/A
- EPS Growth
- PD N/A
- RCKT N/A
- EPS
- PD N/A
- RCKT N/A
- Revenue
- PD $476,132,000.00
- RCKT N/A
- Revenue This Year
- PD $9.60
- RCKT N/A
- Revenue Next Year
- PD $7.56
- RCKT N/A
- P/E Ratio
- PD N/A
- RCKT N/A
- Revenue Growth
- PD 8.55
- RCKT N/A
- 52 Week Low
- PD $13.70
- RCKT $2.19
- 52 Week High
- PD $22.02
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- PD 49.85
- RCKT 45.55
- Support Level
- PD $15.59
- RCKT $2.76
- Resistance Level
- PD $16.18
- RCKT $3.24
- Average True Range (ATR)
- PD 0.46
- RCKT 0.19
- MACD
- PD 0.11
- RCKT 0.17
- Stochastic Oscillator
- PD 68.21
- RCKT 74.85
About PD PagerDuty Inc.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.